PUBLIC COMPANY
save$KYTXKyverna Therapeutics, Inc.
$KYTXEmeryville, CA, USupdated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- —A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- phase2KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome
- phase2KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
- phase2KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
- phase2KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
- phase2KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 13, 26grantGRASSO MARC · Chief Financial Officer10,000 sh
- Mar 13, 26grantGRASSO MARC · Chief Financial Officer65,000 sh
- Mar 13, 26grantBiddle Warner Weston · Chief Executive Officer58,000 sh
- Mar 13, 26grantBiddle Warner Weston · Chief Executive Officer350,000 sh
- Mar 13, 26grantGEHCHAN NAJI · See Remarks18,000 sh
- Mar 13, 26grantGEHCHAN NAJI · See Remarks105,000 sh
🐶 Hiring Signal
News
- Chutes & Ladders—Cue lines up new CMO and research headCue Biopharma is tapping in a new chief medical officer and head of R&D in Dominic Borie, M.D., Ph.D., a physician-scientist with over two decades of industry experience.fiercebiotech · 1mo ago
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that